The UK government says British doctors are overprescribing branded drugs and that pharma marketers are to blame.
One-fifth of general practitioners surveyed said their prescribing behavior was more influenced by pharma marketing than advice from the nation's National Health Service (NHS), according to a Committee of Public Accounts (CPA) study.
The CPA says NHS spends at least $395 million more than it should because UK physicians prescribe higher-cost branded medications rather than cheaper generic versions to their patients.
“It's hard to doubt that the blandishments of the pharmaceutical industry are having an effect,” said Edward Leigh, chairman of the CPA in a published report.
Meanwhile, a separate report from British Parliament concluded that the NHS doesn't adopt new, branded medications at a quick enough pace.